Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
Completed
- Conditions
- Chronic Kidney Disease 5DHeart Failure NYHA Class IIHeart FailureHeart Failure NYHA Class I
- Interventions
- Procedure: Hemodialysis session
- Registration Number
- NCT06394986
- Lead Sponsor
- Moscow Regional Research and Clinical Institute (MONIKI)
- Brief Summary
This is a single-arm cohort study aimed to evaluate change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session after a "long" interdialysis interval.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- signed informed consent,
- > 18 years
- maintenance ("chronic") hemodialysis,
- native arteriovenous fistula,
- arteriovenous fistula volume blood flow ≥1 l/min,
- arteriovenous fistula volume blood flow / cardiac output ratio < 0.3,
- interdialysis weight gain <5% of "dry" body weight,
- sufficient hemodialysis dose (eKt/V > 1.2),
- chronic heart failure (NYHA I-II classes only),
- preserved left ventricular ejection fraction (≥50%),
- absence of arrhythmias (except first-degree atrioventricular block block),
- absence of heart valve disease (except mitral regurgitation grade I-II),
- absence of intradialysis hypo/hypertension
- "long" interdialysis interval (3 days).
Exclusion Criteria
- hypo/hypertension during or after hemodialysis,
- arrhythmias (except first-degree atrioventricular block) after hemodialysis.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Study group Hemodialysis session -
- Primary Outcome Measures
Name Time Method Change in cardio-fistular recirculation One hour before and two hours after the hemodialysis session. Change in arteriovenous fistula volume blood flow / cardiac output ratio
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Moscow Regional Research and Clinical Institute (MONIKI)
🇷🇺Moscow, Russian Federation